Skip to main content
Equibles

NOVO-B · Novo Nordisk A S

Use NOVO-B with AI

Add company filings, earnings and prices to ChatGPT or Claude, then ask questions in your own chat.

Choose your app for step-by-step connection instructions. Sign in with Equibles when asked; no code or API key is needed.

Claude ChatGPT

After connecting, ask your AI to use Equibles to research NOVO-B.

Other apps & server URL
https://mcp.equibles.com/mcp
Gemini CLI setup
or ask here

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

See what you can ask in ChatGPT or Claude

All connection guides →
249.9000 DKK -4.0000 (-1.58%) At close · Oct 8
Rebalance outlook locked

Price & Indicators

Drag to pan · scroll to zoom
Indicators
Price
Panels
Event markers
20d MA 50d MA 200d MA Earnings Investor day
Close249.9000 DKK Open253.9000 DKK Day249.9000–254.9500 DKK 52W close228.5000–401.3500 DKK Avg vol 30d5.2M Last earningsFeb 3, 2027 DataSep 2023–Oct 2026

Raw chart and full-history price indicators begin at the captured split on Sep 13, 2023; bars on opposite sides are not compared.

Technicals

trend & momentum for long-term holders illustrative — not investment advice
Price context
position in its 52-week range
Range low 228.5000 DKK Now 249.9000 DKK · 12% Range high 401.3500 DKK
vs 200-day avg -15% vs 50-day avg -12%

Illustrative technical + ownership context — a signal mix, not investment advice.

Performance

Raw-price comparisons begin at the captured split on Sep 13, 2023; windows that need an earlier baseline remain unavailable.

5D 20D 120D MTD YTD
XCSE:NOVO-B 0.0% -12.7% -4.0% -1.3% -23.2%

Exchange listing

Market
XCSE
Ticker
NOVO-B
ISIN
DK0062498333
Security
—
Trading currency
DKK

Company with tickers: NVO, NONOF

Company

Website
https://www.novonordisk.com/
Investor relations
https://www.novonordisk.com/investors

Other listings of this company

Share classes and depositary receipts can have different prices and dividends.

Recent dividends

Ex-dividend dateAmount per share
2026-08-143.7500 DKK
2026-03-277.9500 DKK
2025-08-153.7500 DKK
2025-03-287.9000 DKK
2024-08-153.5000 DKK
2024-03-226.4000 DKK
2023-08-183.0000 DKK
2023-03-244.0750 DKK
2022-08-122.1250 DKK
2022-03-253.4500 DKK
2021-08-161.7500 DKK
2021-03-262.9250 DKK
2020-08-141.6250 DKK
2020-03-272.6750 DKK

Upcoming investor events

DateEventType
2026-11-04 00:00 UTC Third quarter Event
2027-02-03 00:00 UTC Full-year 2026 results Results publication

Earnings calls

  • Earnings call · Q4 2026 2027-02-03 Scheduled
    Full-year 2026 results
  • Earnings call · Q2 2026 2026-08-05 Audio Transcript
    Second quarter
  • Earnings call · Q1 2026 2026-05-06 Audio Transcript
    First quarter
  • Annual General Meeting · March 2026 2026-03-26
    Annual General Meeting 2026
  • Earnings call · Q4 2025 2025-12-31 Transcript
    Novo Nordisk A S Q4 FY2025 Earnings Call
  • Earnings call · Q3 2025 2025-09-30 Transcript
    Novo Nordisk A S Q3 FY2025 Earnings Call
  • Earnings call · Q2 2025 2025-06-30 Transcript
    Novo Nordisk A S Q2 FY2025 Earnings Call
  • Earnings call · Q1 2025 2025-03-31 Transcript
    Novo Nordisk A S Q1 FY2025 Earnings Call
  • Earnings call · Q3 2024 2024-09-30 Transcript
    Novo Nordisk A S Q3 FY2024 Earnings Call
  • Earnings call · Q2 2024 2024-06-30 Transcript
    Novo Nordisk A S Q2 FY2024 Earnings Call